Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Indian Institute Of Science Education And Research Bhopal has 1 pending office action in the Biotechnology & Pharmaceuticals sector. This matter is being handled by BREEN, KIMBERLY CATHERINE, who is the busiest examiner for the entity. Prosecution is currently limited to 1 distinct examiner and a single distinct art unit.
This narrow footprint suggests that the institution's current US patent activity is highly centralized. Success in this technology area will depend on the outcome of the pending action, making the specific tendencies of BREEN, KIMBERLY CATHERINE a critical factor for the portfolio's immediate growth. The focus on a single art unit indicates a very specific technical application of their research within the biotech field.
Practitioners should analyze the examiner's historical allowance rates to better predict the timeline for this case. Because the entire active workload resides with an individual official, the institution's patent strategy is sensitive to that person's specific requirements. Future expansion may require navigating additional art units as the research foundation broadens its filing strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, HOI YAN NMN | 1 | 38.4% | +75.9% |
| STOFFA, WYATT A | 1 | 79.4% | +22.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262463 | HEPARAN SULFATE AND ITS MIMETICS AS CHEMOKINE INHIBITORS | LEE, HOI YAN NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262463 | HEPARAN SULFATE AND ITS MIMETICS AS CHEMOKINE INHIBITORS | LEE, HOI YAN NMN | — |
| 18258691 | EXCITONIC BOSE-EINSTEIN CONDENSATE (BEC) AS QUBITS USING SEMICONDUCTOR NANOSTRUCTURES FOR QUANTUM TECHNOLOGIES | STOFFA, WYATT A | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 2881 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18262463 | HEPARAN SULFATE AND ITS MIMETICS AS CHEMOKINE INHIBITORS | LEE, HOI YAN NMN | 1693 | §102§103§112 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18258691 | EXCITONIC BOSE-EINSTEIN CONDENSATE (BEC) AS QUBITS USING SEMICONDUCTOR NANOSTRUCTURES FOR QUANTUM TECHNOLOGIES | STOFFA, WYATT A | 2881 | §112 | Final Rejection | — | Pending | Jun 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial